One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry.
Elisabetta MoscarellaAlfonso IelasiAlessandro BeneduceGiuseppe FerranteAndrea Carlo PivatoMauro ChiaritoAlberto CappellettiGiulia PerfettiValeria MagniEugenio PratiStefania FalconeAdele PierriStefano De MartiniMatteo MontorfanoRosario ParisiDavid RutiglianoNicola LocuratoloAngelo AnzuiniPaolo CalabròMaurizio TespiliAlberto MargonatoAlberto BenassiCarlo BriguoriFranco FabbiocchiBernhard ReimersAntonio BartorelliAntonio ColomboCosmo GodinoPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)
In AMI patients, Ultimaster BP-SES implantation was associated with higher rate of TLF and definite stent thrombosis compared with non-AMI patients. The high incidence of adverse events was mainly driven by the unfavorable baseline risk profile.